Drugs / Pfizer mRNA COVID-19 vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06633835 Comparator | Sep → Dec 2024 | COVID-19 | Novavax | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pfizer mRNA COVID-19 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06633835 ↗ |
| Modality | Vaccine | “Pfizer mRNA COVID-19 vaccine” NCT06633835 ↗ |